Zyla Life Sciences Long-Term Debt, Maturity, Year Two
Zyla Life Sciences had Long-Term Debt, Maturity, Year Two of $6.01 million as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2020-05-14
- 2020-03-31: Long-Term Debt, Maturity, Year Two $6.01M.
- 2019-12-31: Long-Term Debt, Maturity, Year Two $6.01M.
- 2019-09-30: Long-Term Debt, Maturity, Year Two $6.56M.
- 2019-06-30: Long-Term Debt, Maturity, Year Two $6.40M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2020-03-31 | $6.01M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $6.01M 10-K · filed 2020-03-26 |
| 2019-09-30 | $6.56M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $6.40M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $6.67M 10-Q · filed 2019-05-17 |
| 2017-12-31 | $320.00K 10-K · filed 2018-03-16 |
| 2016-12-31 | $16.00M 10-K · filed 2017-03-13 |
| 2015-12-31 | $7.15M 10-K · filed 2016-03-11 |